McDonnell Boehnen Hulbert & Berghoff LLP partners Kevin Noonan, Ph.D., Joshua Rich, and Andrew Williams, Ph.D. are quoted in a July 1, 2018 BioPharm International article entitled, “Protecting Biopharm’s Intellectual Capital.” In 30 years, the biopharmaceutical industry has moved light years away from its beginnings in the 1980s, when products such as the first alpha interferons represented the state of the art. View the article
